NEO (NeoGenomics) FFO


NEO NeoGenomics Inc NEO
71 GF Score
Price $14.17
GF Value $16.58
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is NeoGenomics FFO?

FFO (Funds from operations) only applies to REITs.

NEO
71GF Score
NeoGenomics Inc NEO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is NeoGenomics (NEO) Overvalued in 2026?

Based on GuruFocus' analysis, NeoGenomics stock appears to be undervalued. The current stock price of $14.17 is trading 14.5% below its estimated GF Value™ of $16.58. GuruFocus considers NeoGenomics to be Modestly Undervalued.

Key valuation signals for NEO:

  • FFO:
  • GF Value™: $16.58 vs. price of $14.17 (14.5% below fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the NEO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NeoGenomics Business Description

Other Exchanges NEO:MexicoNG9:Germany
Address 9490 NeoGenomics Way, Fort Myers, FL, USA, 33912
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
71GF Score

Get the complete analysis for NEO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.17
Price
$16.58
GF Value